MedNation Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
MedNation has been growing earnings at an average annual rate of 24.4%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been declining at an average rate of 1.4% per year. MedNation's return on equity is 25%, and it has net margins of 6.5%.
Anahtar bilgiler
24.4%
Kazanç büyüme oranı
24.4%
EPS büyüme oranı
Healthcare Sektör Büyümesi | 15.7% |
Gelir büyüme oranı | -1.4% |
Özkaynak getirisi | 25.0% |
Net Marj | 6.5% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
MedNation's (FRA:EIF) Earnings Are Weaker Than They Seem
Oct 07Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost
Oct 03Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost
Oct 03The Return Trends At MedNation (FRA:EIF) Look Promising
Mar 06Investors Still Aren't Entirely Convinced By MedNation AG's (FRA:EIF) Revenues Despite 31% Price Jump
Jan 03These 4 Measures Indicate That MedNation (FRA:EIF) Is Using Debt Extensively
Dec 23MedNation (FRA:EIF) Is Looking To Continue Growing Its Returns On Capital
Oct 10MedNation AG's (FRA:EIF) 32% Dip In Price Shows Sentiment Is Matching Earnings
Jul 29Returns On Capital Are Showing Encouraging Signs At MedNation (FRA:EIF)
Jun 29Returns Are Gaining Momentum At Eifelhöhen-Klinik (FRA:EIF)
Dec 03These 4 Measures Indicate That Eifelhöhen-Klinik (FRA:EIF) Is Using Debt Extensively
Oct 09Is Eifelhöhen-Klinik (FRA:EIF) Using Debt Sensibly?
Jun 03Is Eifelhöhen-Klinik (FRA:EIF) Using Debt In A Risky Way?
Oct 16Is Eifelhöhen-Klinik (FRA:EIF) Using Too Much Debt?
Jun 07Will Eifelhöhen-Klinik's (FRA:EIF) Growth In ROCE Persist?
Feb 22Gelir ve Gider Dağılımı
MedNation nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 47 | 3 | 0 | 0 |
31 Mar 24 | 46 | 3 | 0 | 0 |
31 Dec 23 | 45 | 2 | 0 | 0 |
30 Sep 23 | 43 | 0 | 0 | 0 |
30 Jun 23 | 41 | -2 | 1 | 0 |
31 Mar 23 | 40 | -2 | 1 | 0 |
31 Dec 22 | 39 | -2 | 1 | 0 |
30 Sep 22 | 39 | -3 | 0 | 0 |
30 Jun 22 | 39 | -3 | 0 | 0 |
31 Mar 22 | 38 | -4 | 0 | 0 |
31 Dec 21 | 37 | -4 | 0 | 0 |
30 Sep 21 | 36 | -3 | 0 | 0 |
30 Jun 21 | 35 | -2 | 0 | 0 |
31 Mar 21 | 36 | -2 | 0 | 0 |
31 Dec 20 | 36 | -1 | 0 | 0 |
30 Sep 20 | 39 | -2 | 0 | 0 |
30 Jun 20 | 42 | -2 | 0 | 0 |
31 Mar 20 | 46 | -1 | 0 | 0 |
31 Dec 19 | 50 | -1 | 0 | 0 |
30 Sep 19 | 50 | -1 | 3 | 0 |
30 Jun 19 | 51 | -1 | 5 | 0 |
31 Mar 19 | 51 | -1 | 5 | 0 |
31 Dec 18 | 51 | -1 | 5 | 0 |
30 Sep 18 | 50 | -1 | 5 | 0 |
30 Jun 18 | 49 | 0 | 5 | 0 |
31 Mar 18 | 49 | 0 | 5 | 0 |
31 Dec 17 | 48 | 0 | 5 | 0 |
30 Sep 17 | 48 | 0 | 5 | 0 |
30 Jun 17 | 48 | -1 | 4 | 0 |
31 Mar 17 | 49 | 2 | 4 | 0 |
31 Dec 16 | 49 | 5 | 4 | 0 |
30 Sep 16 | 49 | 5 | 4 | 0 |
30 Jun 16 | 49 | 5 | 3 | 0 |
31 Mar 16 | 48 | 2 | 3 | 0 |
31 Dec 15 | 47 | -1 | 3 | 0 |
30 Sep 15 | 46 | -1 | 3 | 0 |
30 Jun 15 | 44 | -1 | 3 | 0 |
31 Mar 15 | 44 | -1 | 3 | 0 |
31 Dec 14 | 43 | 0 | 3 | 0 |
30 Sep 14 | 42 | 0 | 3 | 0 |
30 Jun 14 | 42 | 1 | 3 | 0 |
31 Mar 14 | 41 | 0 | 3 | 0 |
31 Dec 13 | 40 | 0 | 3 | 0 |
Kaliteli Kazançlar: EIF has a large one-off gain of €2.9M impacting its last 12 months of financial results to 30th June, 2024.
Büyüyen Kar Marjı: EIF became profitable in the past.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: EIF has become profitable over the past 5 years, growing earnings by 24.4% per year.
Büyüme Hızlandırma: EIF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Kazançlar vs. Sektör: EIF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (30.9%).
Özkaynak Getirisi
Yüksek ROE: Whilst EIF's Return on Equity (24.97%) is high, this metric is skewed due to their high level of debt.